Cargando…

Towards an Integral Therapeutic Protocol for Breast Cancer Based upon the New H(+)-Centered Anticancer Paradigm of the Late Post-Warburg Era

A brand new approach to the understanding of breast cancer (BC) is urgently needed. In this contribution, the etiology, pathogenesis, and treatment of this disease is approached from the new pH-centric anticancer paradigm. Only this unitarian perspective, based upon the hydrogen ion (H(+)) dynamics...

Descripción completa

Detalles Bibliográficos
Autores principales: Harguindey, Salvador, Alfarouk, Khalid, Polo Orozco, Julián, Fais, Stefano, Devesa, Jesús
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589677/
https://www.ncbi.nlm.nih.gov/pubmed/33050492
http://dx.doi.org/10.3390/ijms21207475
_version_ 1783600633465536512
author Harguindey, Salvador
Alfarouk, Khalid
Polo Orozco, Julián
Fais, Stefano
Devesa, Jesús
author_facet Harguindey, Salvador
Alfarouk, Khalid
Polo Orozco, Julián
Fais, Stefano
Devesa, Jesús
author_sort Harguindey, Salvador
collection PubMed
description A brand new approach to the understanding of breast cancer (BC) is urgently needed. In this contribution, the etiology, pathogenesis, and treatment of this disease is approached from the new pH-centric anticancer paradigm. Only this unitarian perspective, based upon the hydrogen ion (H(+)) dynamics of cancer, allows for the understanding and integration of the many dualisms, confusions, and paradoxes of the disease. The new H(+)-related, wide-ranging model can embrace, from a unique perspective, the many aspects of the disease and, at the same time, therapeutically interfere with most, if not all, of the hallmarks of cancer known to date. The pH-related armamentarium available for the treatment of BC reviewed here may be beneficial for all types and stages of the disease. In this vein, we have attempted a megasynthesis of traditional and new knowledge in the different areas of breast cancer research and treatment based upon the wide-ranging approach afforded by the hydrogen ion dynamics of cancer. The concerted utilization of the pH-related drugs that are available nowadays for the treatment of breast cancer is advanced.
format Online
Article
Text
id pubmed-7589677
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-75896772020-10-29 Towards an Integral Therapeutic Protocol for Breast Cancer Based upon the New H(+)-Centered Anticancer Paradigm of the Late Post-Warburg Era Harguindey, Salvador Alfarouk, Khalid Polo Orozco, Julián Fais, Stefano Devesa, Jesús Int J Mol Sci Review A brand new approach to the understanding of breast cancer (BC) is urgently needed. In this contribution, the etiology, pathogenesis, and treatment of this disease is approached from the new pH-centric anticancer paradigm. Only this unitarian perspective, based upon the hydrogen ion (H(+)) dynamics of cancer, allows for the understanding and integration of the many dualisms, confusions, and paradoxes of the disease. The new H(+)-related, wide-ranging model can embrace, from a unique perspective, the many aspects of the disease and, at the same time, therapeutically interfere with most, if not all, of the hallmarks of cancer known to date. The pH-related armamentarium available for the treatment of BC reviewed here may be beneficial for all types and stages of the disease. In this vein, we have attempted a megasynthesis of traditional and new knowledge in the different areas of breast cancer research and treatment based upon the wide-ranging approach afforded by the hydrogen ion dynamics of cancer. The concerted utilization of the pH-related drugs that are available nowadays for the treatment of breast cancer is advanced. MDPI 2020-10-10 /pmc/articles/PMC7589677/ /pubmed/33050492 http://dx.doi.org/10.3390/ijms21207475 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Harguindey, Salvador
Alfarouk, Khalid
Polo Orozco, Julián
Fais, Stefano
Devesa, Jesús
Towards an Integral Therapeutic Protocol for Breast Cancer Based upon the New H(+)-Centered Anticancer Paradigm of the Late Post-Warburg Era
title Towards an Integral Therapeutic Protocol for Breast Cancer Based upon the New H(+)-Centered Anticancer Paradigm of the Late Post-Warburg Era
title_full Towards an Integral Therapeutic Protocol for Breast Cancer Based upon the New H(+)-Centered Anticancer Paradigm of the Late Post-Warburg Era
title_fullStr Towards an Integral Therapeutic Protocol for Breast Cancer Based upon the New H(+)-Centered Anticancer Paradigm of the Late Post-Warburg Era
title_full_unstemmed Towards an Integral Therapeutic Protocol for Breast Cancer Based upon the New H(+)-Centered Anticancer Paradigm of the Late Post-Warburg Era
title_short Towards an Integral Therapeutic Protocol for Breast Cancer Based upon the New H(+)-Centered Anticancer Paradigm of the Late Post-Warburg Era
title_sort towards an integral therapeutic protocol for breast cancer based upon the new h(+)-centered anticancer paradigm of the late post-warburg era
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589677/
https://www.ncbi.nlm.nih.gov/pubmed/33050492
http://dx.doi.org/10.3390/ijms21207475
work_keys_str_mv AT harguindeysalvador towardsanintegraltherapeuticprotocolforbreastcancerbaseduponthenewhcenteredanticancerparadigmofthelatepostwarburgera
AT alfaroukkhalid towardsanintegraltherapeuticprotocolforbreastcancerbaseduponthenewhcenteredanticancerparadigmofthelatepostwarburgera
AT poloorozcojulian towardsanintegraltherapeuticprotocolforbreastcancerbaseduponthenewhcenteredanticancerparadigmofthelatepostwarburgera
AT faisstefano towardsanintegraltherapeuticprotocolforbreastcancerbaseduponthenewhcenteredanticancerparadigmofthelatepostwarburgera
AT devesajesus towardsanintegraltherapeuticprotocolforbreastcancerbaseduponthenewhcenteredanticancerparadigmofthelatepostwarburgera